Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

BioAtla (BCAB) Shares Outstanding (2020 - 2025)

BioAtla (BCAB) has disclosed Shares Outstanding for 6 consecutive years, with $63.5 million as the latest value for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 9.23% year-over-year to $63.5 million; the TTM value through Dec 2025 reached $63.5 million, up 9.23%, while the annual FY2025 figure was $63.5 million, 9.23% up from the prior year.
  • Shares Outstanding hit $63.5 million in Q4 2025 for BioAtla, up from $58.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $63.5 million in Q4 2025 and bottomed at $56793.0 in Q3 2023.
  • Average Shares Outstanding over 5 years is $33.0 million, with a median of $47.0 million recorded in 2022.
  • Year-over-year, Shares Outstanding plummeted 96.61% in 2022 and then surged 3866.93% in 2023.
  • BioAtla's Shares Outstanding stood at $35.8 million in 2021, then tumbled by 96.61% to $1.2 million in 2022, then soared by 3866.93% to $48.1 million in 2023, then increased by 20.84% to $58.1 million in 2024, then grew by 9.23% to $63.5 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $63.5 million, $58.8 million, and $58.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.